A citation-based method for searching scientific literature


List of co-cited articles
123 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
20

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
20

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
20

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
549
15

Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study.
M Gokhale, J B Buse, C L Gray, V Pate, M A Marquis, T Stürmer. Diabetes Obes Metab 2014
52
15

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.
Konstantinos K Tsilidis, John C Kasimis, David S Lopez, Evangelia E Ntzani, John P A Ioannidis. BMJ 2015
337
15

Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.
Ralph A DeFronzo, Ted Okerson, Prabhakar Viswanathan, Xuesong Guan, John H Holcombe, Leigh MacConell. Curr Med Res Opin 2008
293
15

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
15


Adherence to therapies in patients with type 2 diabetes.
Luis-Emilio García-Pérez, María Alvarez, Tatiana Dilla, Vicente Gil-Guillén, Domingo Orozco-Beltrán. Diabetes Ther 2013
328
15



Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen,[...]. N Engl J Med 2019
434
15

Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.
Mark S Fineman, Larry Z Shen, Kristin Taylor, Dennis D Kim, Alain D Baron. Diabetes Metab Res Rev 2004
165
15


Small molecule drug discovery at the glucagon-like peptide-1 receptor.
Francis S Willard, Ana B Bueno, Kyle W Sloop. Exp Diabetes Res 2012
51
10

An overview of new GLP-1 receptor agonists for type 2 diabetes.
Brian Tomlinson, Miao Hu, Yuzhen Zhang, Paul Chan, Zhong-Min Liu. Expert Opin Investig Drugs 2016
31
10

Small-molecule agonists for the glucagon-like peptide 1 receptor.
Lotte Bjerre Knudsen, Dan Kiel, Min Teng, Carsten Behrens, Dilip Bhumralkar, János T Kodra, Jens J Holst, Claus B Jeppesen, Michael D Johnson, Johannes Cornelis de Jong,[...]. Proc Natl Acad Sci U S A 2007
158
10

Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
Christina Rye Underwood, Patrick Garibay, Lotte Bjerre Knudsen, Sven Hastrup, Günther H Peters, Rainer Rudolph, Steffen Reedtz-Runge. J Biol Chem 2010
196
10

Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM).
Lindsey C Morris, Kellie D Nance, Patrick R Gentry, Emily L Days, C David Weaver, Colleen M Niswender, Analisa D Thompson, Carrie K Jones, Chuck W Locuson, Ryan D Morrison,[...]. J Med Chem 2014
26
10

Structure of the human glucagon class B G-protein-coupled receptor.
Fai Yiu Siu, Min He, Chris de Graaf, Gye Won Han, Dehua Yang, Zhiyun Zhang, Caihong Zhou, Qingping Xu, Daniel Wacker, Jeremiah S Joseph,[...]. Nature 2013
271
10

Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function.
Cassandra Koole, Kavita Pabreja, Emilia E Savage, Denise Wootten, Sebastian G B Furness, Laurence J Miller, Arthur Christopoulos, Patrick M Sexton. Biochem Soc Trans 2013
49
10

Structure-based discovery of allosteric modulators of two related class B G-protein-coupled receptors.
Chris de Graaf, Chantal Rein, David Piwnica, Fabrizio Giordanetto, Didier Rognan. ChemMedChem 2011
53
10

Allosteric modulation of G protein-coupled receptors.
Lauren T May, Katie Leach, Patrick M Sexton, Arthur Christopoulos. Annu Rev Pharmacol Toxicol 2007
501
10

Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.
Denise Wootten, John Simms, Laurence J Miller, Arthur Christopoulos, Patrick M Sexton. Proc Natl Acad Sci U S A 2013
131
10

Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids.
Denise Wootten, John Simms, Cassandra Koole, Owen L Woodman, Roger J Summers, Arthur Christopoulos, Patrick M Sexton. J Pharmacol Exp Ther 2011
51
10

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.
Desu Chen, Jiayu Liao, Na Li, Caihong Zhou, Qing Liu, Guangxing Wang, Rui Zhang, Song Zhang, Lilin Lin, Kaixian Chen,[...]. Proc Natl Acad Sci U S A 2007
128
10

Structure of class B GPCR corticotropin-releasing factor receptor 1.
Kaspar Hollenstein, James Kean, Andrea Bortolato, Robert K Y Cheng, Andrew S Doré, Ali Jazayeri, Robert M Cooke, Malcolm Weir, Fiona H Marshall. Nature 2013
305
10

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.
Brian Finan, Bin Yang, Nickki Ottaway, David L Smiley, Tao Ma, Christoffer Clemmensen, Joe Chabenne, Lianshan Zhang, Kirk M Habegger, Katrin Fischer,[...]. Nat Med 2015
314
10

Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis.
Kelly B Stein, Claire F Snyder, Bethany B Barone, Hsin-Chieh Yeh, Kimberly S Peairs, Rachel L Derr, Antonio C Wolff, Frederick L Brancati. Dig Dis Sci 2010
99
10


Diabetes mellitus, fasting glucose, and risk of cause-specific death.
Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, Emanuele Di Angelantonio, Pei Gao, Nadeem Sarwar, Peter H Whincup, Kenneth J Mukamal, Richard F Gillum, Ingar Holme,[...]. N Engl J Med 2011
10

The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia.
Louise Bordeleau, Natalia Yakubovich, Gilles R Dagenais, Julio Rosenstock, Jeffrey Probstfield, Pan Chang Yu, Lars E Ryden, Valdis Pirags, Giatgen A Spinas, Kare I Birkeland,[...]. Diabetes Care 2014
57
10

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
10

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Marie Ng, Tom Fleming, Margaret Robinson, Blake Thomson, Nicholas Graetz, Christopher Margono, Erin C Mullany, Stan Biryukov, Cristiana Abbafati, Semaw Ferede Abera,[...]. Lancet 2014
10

Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.
J M Jonasson, R Ljung, M Talbäck, B Haglund, S Gudbjörnsdòttir, G Steineck. Diabetologia 2009
308
10

The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.
Marco Tuccori, Jennifer W Wu, Hui Yin, Agnieszka Majdan, Laurent Azoulay. Diabetes Care 2015
19
10

GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.
Jacqueline A Koehler, Laurie L Baggio, Bernardo Yusta, Christine Longuet, Katherine J Rowland, Xiemin Cao, Dianne Holland, Patricia L Brubaker, Daniel J Drucker. Cell Metab 2015
68
10

Cancer occurrence in Danish diabetic patients: duration and insulin effects.
B Carstensen, D R Witte, S Friis. Diabetologia 2012
116
10

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.
Sara Gandini, Matteo Puntoni, Brandy M Heckman-Stoddard, Barbara K Dunn, Leslie Ford, Andrea DeCensi, Eva Szabo. Cancer Prev Res (Phila) 2014
226
10


New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.
Gillian Libby, Louise A Donnelly, Peter T Donnan, Dario R Alessi, Andrew D Morris, Josie M M Evans. Diabetes Care 2009
741
10

Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study.
Lillian R Meacham, Charles A Sklar, Suwen Li, Qi Liu, Nora Gimpel, Yutaka Yasui, John A Whitton, Marilyn Stovall, Leslie L Robison, Kevin C Oeffinger. Arch Intern Med 2009
193
10

Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies.
D Bansal, A Bhansali, G Kapil, K Undela, P Tiwari. Prostate Cancer Prostatic Dis 2013
115
10

Pre-existing diabetes and breast cancer prognosis among elderly women.
J Luo, M Hendryx, B Virnig, S Wen, R Chlebowski, C Chen, T Rohan, L Tinker, J Wactawski-Wende, L Lessin,[...]. Br J Cancer 2015
23
10

Pancreatic safety of incretin-based drugs--FDA and EMA assessment.
Amy G Egan, Eberhard Blind, Kristina Dunder, Pieter A de Graeff, B Timothy Hummer, Todd Bourcier, Curtis Rosebraugh. N Engl J Med 2014
325
10

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.
Tomasz P Srokowski, Shenying Fang, Gabriel N Hortobagyi, Sharon H Giordano. J Clin Oncol 2009
141
10

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.
James D Lewis, Assiamira Ferrara, Tiffany Peng, Monique Hedderson, Warren B Bilker, Charles P Quesenberry, David J Vaughn, Lisa Nessel, Joseph Selby, Brian L Strom. Diabetes Care 2011
437
10

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.
L G Hemkens, U Grouven, R Bender, C Günster, S Gutschmidt, G W Selke, P T Sawicki. Diabetologia 2009
438
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.